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Introduction
Systemic juvenile idiopathic arthritis (JIA) is a subtype
of childhood arthritis associated with significant sys-
temic inflammation as well as arthritis. Hyaluronic acid
as a constituent of connective tissue has previously been
described as a marker for arthritis in JIA in an Asian
population. Mutations in hyaluronic acid synthase 2
leading to accumulation of hyaluronic acid have been
found to be associated with a periodic fever syndrome
in Shar-Pei dogs. Hyaluronic acid has therefore been
suspected as a risk factor for systemic inflammation in
humans.
Objectives
To investigate the correlation of hyaluronic acid levels
with clinical manifestations and markers of inflamma-
tion in patients with systemic juvenile idiopathic
arthritis.
Methods
Patient sera and clinical data were acquired from the
AIDnet database, a German database and biobank
where samples from patients with inflammatory syn-
dromes including periodic fevers syndromes and sys-
temic JIA are collected prospectively. A single center
sample of all patients diagnosed with systemic JIA was
obtained, and hyaluronic acid levels were determined
from frozen sera samples. Demographic data, data on
medication and laboratory data on inflammatory para-
meters (C-reactive protein, ESR, S100A8/A9 and
S100A12) from the time points the serum samples were
obtained were extracted from the AIDnet database. A
retrospective chart survey was used to determine sys-
temic inflammatory activity and arthritis activity.
Patients were deemed to have systemic activity if they
had fever and at least one other symptom according to
the ILAR criteria at time of obtaining the sample, and
were deemed to have active arthritis if they had at least
one swollen joint or tenderness and limitation of motion
at time of obtaining the sample. Univariate analysis was
performed using descriptive statistics, Student’s T-test
and the Pearson correlation coefficient.
Results
25 patients were included in the study, of which 13 had
active arthritis and 3 active systemic symptoms at time
of sampling. 48% were treated with prednisone, 76%
with a DMARD and 72% with a biologic drug at time of
sampling. Patients with systemic symptoms had a mean
level of hyaluronic acid of 61.0 μg/l, compared to 134.5
μg/l in patients with no systemic symptoms (p = 0.330).
However, patients with active arthritis had a mean level
of hyaluronic acid of 180.5 μg/l, compared to 48.1
mg/l in patients without active arthritis (p = 0.002). No
significant correlations were found between levels of
hyaluronic acid and levels of CRP, ESR, S100A8/A9 and
S100A12.
Conclusion
In this Caucasian population, hyaluronic acid levels are
correlated with clinical arthritis, but not with systemic
activity or inflammatory parameters in systemic juvenile
idiopathic arthritis. Hyaluronic acid does not appear to
be a driver of systemic inflammation in sJIA.
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